Need help finding what you are looking for?
Contact Us
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2132778
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2132778
Peptide Synthesis Market by Instruments (Synthesizers, Purification, Lyophilizers, Analytical), Reagents (Amino Acids, Resins), Technique (Chemical, Biological), Services (Custom Synthesis, Modification), Application, End User - Global Forecast to 2031
PUBLISHED:
PAGES: 666 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global peptide synthesis market is estimated to reach USD 1.54 billion by 2031 from USD 0.98 billion in 2026, at a CAGR of 9.5% from 2026 to 2031. The market is projected to grow steadily over the forecast period, driven by the expanding pipeline of peptide-based therapeutics, rising demand for GLP-1 and other metabolic peptides, and broader use of synthetic peptides in oncology, diagnostics, and research. Growth is further supported by advances in automated solid-phase peptide synthesis, high-throughput platforms, specialized modification chemistries, and peptide purification and analytical technologies.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Offering, Product Type, Technique, Service Type, Application, Product End User, and Service End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
However, high material and solvent consumption, synthesis complexity for long and difficult sequences, purification challenges, and the need for specialized technical expertise are expected to restrain broader market growth.
"The custom peptide synthesis services segment accounted for the largest share, by service type, in 2025."
Based on service type, the peptide synthesis services market is segmented into custom peptide synthesis services, peptide engineering & modification services, peptide purification services, peptide analytical & characterization services, and peptide library preparation/synthesis services. In 2025, custom peptide synthesis services accounted for the largest market share, driven by growing outsourcing of standard, high-purity, modified, long, and complex peptide requirements. These services are widely used across drug discovery, therapeutic development, diagnostic research, antibody generation, and academic research workflows. Demand is further supported by increasing requirements for rapid turnaround, customized purity levels, difficult sequences, and specialized peptide formats. Their broad applicability across pharmaceutical & biotechnology companies, CROs & CDMOs, and academic & research institutes continues to support the segment's leading position globally.
"Chemical synthesis segment accounted for the largest share of the peptide synthesis products market, by technique, in 2025."
Based on technique, the peptide synthesis products market is segmented into chemical synthesis and biological synthesis. Chemical synthesis accounted for the largest market share in 2025, due to the widespread use of solid-phase peptide synthesis (SPPS) for research and therapeutic peptide production. SPPS offers established Fmoc- and Boc-based chemistries, compatibility with automation, sequence flexibility, and a broad ecosystem of synthesizers, resins, protected amino acids, and coupling reagents. Liquid-phase synthesis, hybrid approaches, and chemical ligation methods complement SPPS for selected fragments and complex sequences. The maturity of chemical synthesis workflows and their extensive use across pharmaceutical, biotechnology, CRO, and academic laboratories continue to support the segment's leading position.
"Asia Pacific is expected to register the highest CAGR in the peptide synthesis market from 2026 to 2031."
The peptide synthesis market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Asia Pacific is estimated to grow at the highest CAGR during the forecast period, driven by expanding pharmaceutical and biotechnology R&D, growing peptide drug development, rising outsourcing of custom peptide synthesis, and improvements in research infrastructure. Growth is further supported by increasing adoption of automated peptide synthesizers, advanced purification and analytical platforms, and expanding demand for peptide therapeutics across China, India, Japan, South Korea, and Australia. Established regional suppliers and expanding global life-science operations continue to strengthen peptide synthesis capabilities across the region.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side (80%) and Demand Side (20%)
- By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
- By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%)
Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), GenScript Biotech Corporation (China), Kaneka Corporation (Japan), Biotage AB (Sweden), Sartorius AG (Germany), Bachem Holding AG (Switzerland), CEM Corporation (US), Bio-Synthesis, Inc. (US), Biosynth (Switzerland), CSBio (US), GL Biochem (Shanghai) Ltd. (China), Mesa Laboratories, Inc. (US), Danaher Corporation (US), Chem-Impex International, Inc. (US), Advanced ChemTech (ACT) (US), Mimotopes Pty Ltd (Australia), Iris Biotech GmbH (Germany), AAPPTec, LLC (US), Enamine Ltd. (Ukraine), Intavis Peptide Services (Germany), JPT Peptide Technologies GmbH (Germany), Innovagen AB (Sweden), Peptide Protein Research Ltd. (UK), LifeTein LLC (US), Creative Peptides (US), Genemed Synthesis, Inc. (US), ChinaPeptides Co., Ltd. (China), and Beijing Scilight Biotechnology Co., Ltd. (China) are some of the key companies offering peptide synthesis products and services.
Research Coverage
This research report categorizes the peptide synthesis market by offering (products, services), product type (instruments, reagents & consumables), technique (chemical synthesis, biological synthesis), service type (custom peptide synthesis services, peptide engineering & modification services, peptide purification services, peptide analytical & characterization services, peptide library preparation/synthesis services), application (therapeutic applications, diagnostics applications, research applications), product end user (pharmaceutical & biotechnology companies, CROs & CDMOs, academic & research institutes, medical device companies, clinical & diagnostic laboratories), service end user (pharmaceutical & biotechnology companies, CROs & CDMOs, academic & research institutes, medical device companies, clinical & diagnostic laboratories), and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).
The scope of the report provides detailed information on major factors such as drivers, challenges, opportunities, and restraints that influence the growth of the peptide synthesis market. A comprehensive analysis of key industry players has been conducted to provide insights into their business overviews, product & services portfolios, and key strategies, including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments in the peptide synthesis market.
Key Benefits of Buying the Report
This report offers a comprehensive overview of the peptide synthesis market. It aims to assess the market size and future growth opportunities across various segments. The report also features an in-depth competitive analysis of the major market players, including their company profiles, recent developments, and key market strategies:
The report provides insights on the following pointers:
- Analysis of key drivers (surging demand for GLP-1 and other high-volume peptide therapeutics, rising complexity of peptide modalities requiring advanced synthesis and purification, expanding peptide drug pipelines and clinical development activity), restraints (high material consumption and waste generation in large-scale peptide synthesis, high cost and supply sensitivity of GMP-grade synthesis inputs), opportunities (rapid expansion of global GMP peptide manufacturing capacity, shift toward continuous-flow, hybrid, and solvent-efficient peptide synthesis technologies), and challenges (maintaining yield, purity, and batch consistency for complex peptides at scale) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products & services of the peptide synthesis market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the peptide synthesis market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), GenScript Biotech Corporation (China), Kaneka Corporation (Japan), Biotage AB (Sweden), Sartorius AG (Germany), Bachem Holding AG (Switzerland), CEM Corporation (US), Bio-Synthesis, Inc. (US), Biosynth (Switzerland), CSBio (US), GL Biochem (Shanghai) Ltd. (China), Mesa Laboratories, Inc. (US), Danaher Corporation (US), Chem-Impex International, Inc. (US), Advanced ChemTech (ACT) (US), Mimotopes Pty Ltd (Australia), Iris Biotech GmbH (Germany), AAPPTec, LLC (US), Enamine Ltd. (Ukraine), Intavis Peptide Services (Germany), JPT Peptide Technologies GmbH (Germany), Innovagen AB (Sweden), Peptide Protein Research Ltd. (UK), LifeTein LLC (US), Creative Peptides (US), Genemed Synthesis, Inc. (US), ChinaPeptides Co., Ltd. (China), and Beijing Scilight Biotechnology Co., Ltd. (China).
The report also helps stakeholders understand trends in the peptide synthesis market and provides information on key drivers, restraints, challenges, and opportunities. A detailed analysis of the key industry players has been conducted to offer insights into their strategies, product & services launches, acquisitions, partnerships, collaborations, recent activities, investments, funding, brand/product/service comparisons, vendor evaluations, and financial metrics of the peptide synthesis sector.
Product Code: BT 6462
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 STAKEHOLDERS
- 1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
- 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS IN PEPTIDE SYNTHESIS MARKET
- 2.4 HIGH-GROWTH SEGMENTS
- 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 PEPTIDE SYNTHESIS MARKET OVERVIEW
- 3.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING
- 3.3 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 3.4 PEPTIDE SYNTHESIS MARKET SHARE, BY APPLICATION, 2026 VS. 2031 (%)
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Surging demand for GLP-1 and other high-volume peptide therapeutics
- 4.2.1.2 Rising complexity of peptide modalities requiring advanced synthesis and purification
- 4.2.1.3 Expanding peptide drug pipelines and clinical development activity
- 4.2.2 RESTRAINTS
- 4.2.2.1 High material consumption and waste generation in large-scale solid-phase peptide synthesis
- 4.2.2.2 High cost and supply sensitivity of GMP-grade synthesis inputs
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Rapid expansion of global GMP peptide manufacturing capacity
- 4.2.3.2 Shift toward continuous-flow, hybrid, and solvent-efficient peptide synthesis technologies
- 4.2.4 CHALLENGES
- 4.2.4.1 Maintaining yield, purity, and batch consistency for complex peptides at scale
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS & WHITE SPACES
- 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 BARGAINING POWER OF SUPPLIERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS & FORECAST
- 5.2.3 TRENDS IN GLOBAL PEPTIDE SYNTHESIS MARKET
- 5.3 VALUE CHAIN ANALYSIS
- 5.4 ECOSYSTEM ANALYSIS
- 5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
- 5.5.2 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION
- 5.6 TRADE ANALYSIS
- 5.6.1 IMPORT SCENARIO (HS CODE 902720)
- 5.6.2 EXPORT SCENARIO (HS CODE 902720)
- 5.6.3 IMPORT SCENARIO (HS CODE 841933)
- 5.6.4 EXPORT SCENARIO (HS CODE 841933)
- 5.7 KEY CONFERENCES & EVENTS, 2026-2027
- 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.9 INVESTMENT & FUNDING ACTIVITY
- 5.10 IMPACT OF 2025 US TARIFFS ON PEPTIDE SYNTHESIS MARKET
- 5.10.1 INTRODUCTION
- 5.10.2 PRICE IMPACT ANALYSIS
- 5.10.3 IMPACT ON COUNTRY/REGION
- 5.10.3.1 North America
- 5.10.3.2 Europe
- 5.10.3.3 Asia Pacific
- 5.10.4 IMPACT ON END-USE INDUSTRIES
- 5.10.4.1 Pharmaceutical & biotechnology companies
- 5.10.4.2 CROs & CDMOs
- 5.10.4.3 Academic & research institutes, diagnostic labs, and other end users
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS
- 6.1 TECHNOLOGY ANALYSIS
- 6.1.1 KEY EMERGING TECHNOLOGIES
- 6.1.1.1 Solid-phase peptide synthesis (SPPS)
- 6.1.1.2 Liquid-phase peptide synthesis (LPPS)
- 6.1.1.3 Enzymatic peptide synthesis
- 6.1.1.4 Recombinant peptide synthesis
- 6.1.1.5 Continuous-flow peptide synthesis
- 6.1.2 COMPLEMENTARY TECHNOLOGIES
- 6.1.2.1 Analytical characterization & quality-control technologies
- 6.1.2.2 Purification & downstream processing technologies
- 6.1.2.3 Peptide ligation technologies
- 6.1.3 ADJACENT TECHNOLOGIES
- 6.1.3.1 Protein design & engineering
- 6.1.3.2 Synthetic biology/genetic-code engineering
- 6.1.1 KEY EMERGING TECHNOLOGIES
- 6.2 TECHNOLOGY/PRODUCT ROADMAP
- 6.3 PATENT ANALYSIS
- 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR PEPTIDE SYNTHESIS PATENTS
- 6.4 FUTURE APPLICATIONS
- 6.5 IMPACT OF AI/GEN AI ON PEPTIDE SYNTHESIS MARKET
- 6.5.1 BEST PRACTICES IN PEPTIDE SYNTHESIS WORKFLOW
- 6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN PEPTIDE SYNTHESIS MARKET
- 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
- 6.5.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN PEPTIDE SYNTHESIS MARKET
7 SUSTAINABILITY & REGULATORY LANDSCAPE
- 7.1 REGIONAL REGULATIONS & COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 REGULATORY FRAMEWORK
- 7.1.3 INDUSTRY STANDARDS
- 7.2 SUSTAINABILITY INITIATIVES
- 7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
- 7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 KEY BUYING CRITERIA, BY END USER
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM END USERS
- 8.5 MARKET PROFITABILITY
9 PEPTIDE SYNTHESIS MARKET, BY OFFERING
- 9.1 INTRODUCTION
- 9.2 PRODUCTS
- 9.2.1 IN-HOUSE WORKFLOW CONTROL AND RECURRING PEPTIDE-SPECIFIC DEMAND TO DRIVE MARKET GROWTH
- 9.3 SERVICES
- 9.3.1 GROWING OUTSOURCING OF COMPLEX AND VARIABLE-VOLUME PEPTIDE PROJECTS TO SUPPORT MARKET GROWTH
10 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE
- 10.1 INTRODUCTION
- 10.2 REAGENTS & CONSUMABLES
- 10.2.1 REAGENTS
- 10.2.1.1 Amino acid building blocks
- 10.2.1.1.1 Expanding use of protected and non-natural residues to drive demand for amino acid building blocks
- 10.2.1.2 Resins
- 10.2.1.2.1 Broader linker chemistry and high-throughput SPPS formats to support steady resin demand
- 10.2.1.3 Coupling reagents
- 10.2.1.3.1 Need for faster activation and lower side-reaction risk to sustain demand for advanced coupling chemistry
- 10.2.1.4 Peptide modification reagents
- 10.2.1.4.1 Half-life extension, targeting, and conjugation strategies to make modification reagents fastest-growing reagent category
- 10.2.1.5 Labeling reagents
- 10.2.1.5.1 Rising use of labeled peptides in imaging, diagnostics, binding studies, and assay development to expand demand
- 10.2.1.6 Protection & deprotection reagents
- 10.2.1.6.1 Orthogonal protecting strategies and pressure to reduce hazardous chemistry to shape product selection
- 10.2.1.7 Cleavage reagents
- 10.2.1.7.1 Continued SPPS use and demand for cleaner cleavage profiles to support recurring cleavage-chemistry purchases
- 10.2.1.8 Other reagents
- 10.2.1.1 Amino acid building blocks
- 10.2.2 CONSUMABLES
- 10.2.2.1 Higher synthesis throughput and purification workload to support steady recurring consumables demand
- 10.2.1 REAGENTS
- 10.3 INSTRUMENTS
- 10.3.1 PEPTIDE SYNTHESIZERS
- 10.3.1.1 Peptide synthesizers, by type
- 10.3.1.1.1 Automated peptide synthesizers
- 10.3.1.1.2 Manual peptide synthesizers
- 10.3.1.2 Peptide synthesizers, by technology
- 10.3.1.2.1 Conventional-batch peptide synthesizers
- 10.3.1.2.2 Microwave-assisted peptide synthesizers
- 10.3.1.2.3 Hybrid peptide synthesizers
- 10.3.1.2.4 Other peptide synthesizers
- 10.3.1.1 Peptide synthesizers, by type
- 10.3.2 PURIFICATION SYSTEMS
- 10.3.2.1 Higher crude-peptide complexity and throughput bottlenecks to increase demand for scalable purification platforms
- 10.3.3 ANALYTICAL & QUALITY CONTROL INSTRUMENTS
- 10.3.3.1 Impurity profiling, identity confirmation, and tighter peptide quality requirements to sustain analytical platform investment
- 10.3.4 LYOPHILIZATION EQUIPMENT
- 10.3.4.1 Need for stable dry peptide formats and scale-appropriate freeze-drying capacity to support demand
- 10.3.5 OTHER INSTRUMENTS
- 10.3.1 PEPTIDE SYNTHESIZERS
11 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TECHNIQUE
- 11.1 INTRODUCTION
- 11.2 CHEMICAL SYNTHESIS
- 11.2.1 SOLID-PHASE PEPTIDE SYNTHESIS (SPPS)
- 11.2.1.1 Automation, rapid iterative chemistry, and commercial-scale familiarity to sustain SPPS as largest chemical synthesis method
- 11.2.2 LIQUID-PHASE PEPTIDE SYNTHESIS (LPPS)
- 11.2.2.1 Solvent-efficiency improvements and large-scale economics to make LPPS fastest-growing chemical synthesis method
- 11.2.3 OTHER CHEMICAL METHODS
- 11.2.1 SOLID-PHASE PEPTIDE SYNTHESIS (SPPS)
- 11.3 BIOLOGICAL SYNTHESIS
- 11.3.1 RECOMBINANT PEPTIDE PRODUCTION
- 11.3.1.1 Scalable microbial expression and established biologics infrastructure to keep recombinant production dominant within biological synthesis
- 11.3.2 ENZYMATIC PEPTIDE SYNTHESIS
- 11.3.2.1 High selectivity and lower-solvent ligation to position enzymatic synthesis as fastest-growing biological method
- 11.3.1 RECOMBINANT PEPTIDE PRODUCTION
12 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER
- 12.1 INTRODUCTION
- 12.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 12.2.1 EXPANDING PEPTIDE PIPELINES AND IN-HOUSE MANUFACTURING CAPABILITIES TO DRIVE MARKET GROWTH
- 12.3 CROS & CDMOS
- 12.3.1 RAPID OUTSOURCING AND CAPACITY EXPANSION TO MAKE CROS & CDMOS FASTEST-GROWING PRODUCT END-USER CATEGORY
- 12.4 ACADEMIC & RESEARCH INSTITUTES
- 12.4.1 DISCOVERY-LED PEPTIDE LIBRARIES AND GREATER ACCESS TO AUTOMATED BENCHTOP SYSTEMS TO SUSTAIN RESEARCH INSTITUTE DEMAND
- 12.5 MEDICAL DEVICE COMPANIES
- 12.5.1 PEPTIDE-FUNCTIONALIZED BIOSENSORS AND SURFACE-ENGINEERED DEVICES TO BROADEN SPECIALIZED DEMAND FOR MODIFIED SYNTHESIS PRODUCTS
- 12.6 CLINICAL & DIAGNOSTIC LABORATORIES
- 12.6.1 HIGHER ASSAY SPECIFICITY AND STANDARDIZED PEPTIDE REAGENTS TO SUPPORT ADOPTION IN CLINICAL AND DIAGNOSTIC LABORATORIES
13 PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE
- 13.1 INTRODUCTION
- 13.2 CUSTOM PEPTIDE SYNTHESIS SERVICES
- 13.2.1 FLEXIBLE SEQUENCE, PURITY, AND QUANTITY REQUIREMENTS TO KEEP CUSTOM PEPTIDE SYNTHESIS SERVICES LARGEST SERVICE CATEGORY
- 13.3 PEPTIDE ENGINEERING & MODIFICATION SERVICES
- 13.3.1 GROWING NEED FOR HALF-LIFE EXTENSION, TARGETING, AND CONJUGATION TO MAKE ENGINEERING & MODIFICATION SERVICES FASTEST-GROWING CATEGORY
- 13.4 PEPTIDE PURIFICATION SERVICES
- 13.4.1 MORE DIFFICULT PEPTIDE SEQUENCES AND TIGHTER PURITY SPECIFICATIONS TO SUSTAIN DEMAND FOR OUTSOURCED PURIFICATION
- 13.5 PEPTIDE ANALYTICAL & CHARACTERIZATION SERVICES
- 13.5.1 RISING MOLECULAR COMPLEXITY AND QUALITY EXPECTATIONS TO EXPAND PEPTIDE ANALYTICAL & CHARACTERIZATION OUTSOURCING
- 13.6 PEPTIDE LIBRARY PREPARATION/SYNTHESIS SERVICES
- 13.6.1 HIGH-THROUGHPUT SCREENING AND IMMUNE-MONITORING WORKFLOWS TO INCREASE ADOPTION OF PEPTIDE LIBRARY SERVICES
14 PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER
- 14.1 INTRODUCTION
- 14.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 14.2.1 BROAD OUTSOURCING ACROSS DISCOVERY AND DEVELOPMENT TO BOOST MARKET GROWTH
- 14.3 CROS & CDMOS
- 14.3.1 EXTERNAL CAPACITY, SPECIALIZED CHEMISTRY, AND NETWORK FLEXIBILITY TO MAKE CROS & CDMOS FASTEST-GROWING SERVICE END-USER CATEGORY
- 14.4 ACADEMIC & RESEARCH INSTITUTES
- 14.4.1 FLEXIBLE PROJECT-SCALE OUTSOURCING AND SPECIALIZED PEPTIDE FORMATS TO SUSTAIN DEMAND FROM ACADEMIC & RESEARCH INSTITUTES
- 14.5 MEDICAL DEVICE COMPANIES
- 14.5.1 PEPTIDE-FUNCTIONALIZED DEVICES AND BIOSENSORS TO INCREASE DEMAND FOR SPECIALIZED SYNTHESIS, MODIFICATION, AND CONJUGATION SERVICES
- 14.6 CLINICAL & DIAGNOSTIC LABORATORIES
- 14.6.1 ASSAY STANDARDIZATION AND CLINICAL-GRADE QUALITY REQUIREMENTS TO SUPPORT OUTSOURCED PEPTIDE SERVICES FOR DIAGNOSTIC LABORATORIES
15 PEPTIDE SYNTHESIS MARKET, BY APPLICATION
- 15.1 INTRODUCTION
- 15.2 THERAPEUTIC APPLICATIONS
- 15.2.1 THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION
- 15.2.1.1 Diabetes
- 15.2.1.1.1 Large established peptide classes and sustained need for high-purity analogs drive growth
- 15.2.1.2 Obesity
- 15.2.1.2.1 Late-stage dual- and triple-agonist pipelines and rapid commercial scale-up to make obesity fastest-growing therapeutic indication
- 15.2.1.3 Cancer
- 15.2.1.3.1 Targeted delivery, neoantigen programs, and radioligand development to deepen peptide-synthesis requirements in oncology
- 15.2.1.4 Autoimmune disease
- 15.2.1.4.1 Targeted oral peptides and antigen-specific immunomodulation to broaden peptide use in chronic autoimmune disorders
- 15.2.1.5 Other therapeutic indications
- 15.2.1.1 Diabetes
- 15.2.2 THERAPEUTIC APPLICATIONS, BY MOLECULE
- 15.2.2.1 Metabolic & hormonal peptides
- 15.2.2.1.1 High-volume incretin, insulin, and hormone-peptide demand to drive market growth
- 15.2.2.2 Peptide inhibitors
- 15.2.2.2.1 Improved oral delivery, structural constraint, and access to difficult protein interfaces to expand peptide inhibitor development
- 15.2.2.3 Peptide-drug conjugates (PDCs)
- 15.2.2.3.1 Targeted payload delivery and radioconjugate pipelines to make PDCs fastest-growing therapeutic molecule category
- 15.2.2.4 Peptide-based vaccines
- 15.2.2.4.1 Neoepitope discovery, immune monitoring, and personalized vaccine strategies to support high-diversity peptide synthesis demand
- 15.2.2.5 Other therapeutic modalities
- 15.2.2.1 Metabolic & hormonal peptides
- 15.2.1 THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION
- 15.3 RESEARCH APPLICATIONS
- 15.3.1 HIGH-THROUGHPUT DISCOVERY, BIOMARKER STUDIES, AND RECURRING CUSTOM-PEPTIDE USE TO SUSTAIN BROAD RESEARCH DEMAND BASE
- 15.4 DIAGNOSTIC APPLICATIONS
- 15.4.1 PEPTIDE-BASED ASSAY REAGENTS, IMAGING LIGANDS, AND COMPANION-DIAGNOSTIC DEVELOPMENT TO EXPAND SPECIALIZED DIAGNOSTIC DEMAND
16 PEPTIDE SYNTHESIS MARKET, BY REGION
- 16.1 INTRODUCTION
- 16.2 NORTH AMERICA
- 16.2.1 US
- 16.2.1.1 Dense peptide pipelines and domestic capacity to sustain market growth
- 16.2.2 CANADA
- 16.2.2.1 Biopharma manufacturing investment and research demand to support steady expansion
- 16.2.1 US
- 16.3 EUROPE
- 16.3.1 GERMANY
- 16.3.1.1 Integrated peptide manufacturing and strong chemical supply chains to support demand
- 16.3.2 UK
- 16.3.2.1 Research intensity and diagnostic peptide capability to support specialized demand
- 16.3.3 FRANCE
- 16.3.3.1 Expanding SPPS capacity to strengthen commercial peptide supply base
- 16.3.4 ITALY
- 16.3.4.1 Injectable manufacturing integration to support peptide development-to-product workflows
- 16.3.5 SPAIN
- 16.3.5.1 Research and specialty-pharma activity to sustain demand for imported synthesis solutions
- 16.3.6 REST OF EUROPE
- 16.3.1 GERMANY
- 16.4 ASIA PACIFIC
- 16.4.1 CHINA
- 16.4.1.1 Large-scale TIDES capacity and domestic supplier depth to accelerate market expansion
- 16.4.2 JAPAN
- 16.4.2.1 Advanced drug discovery and specialty peptide innovation to sustain high-value demand
- 16.4.3 INDIA
- 16.4.3.1 Cost-efficient CRDMO expansion and new peptide capacity to accelerate market growth
- 16.4.4 SOUTH KOREA
- 16.4.4.1 Biotech investment and long-acting peptide development to expand specialized demand
- 16.4.5 AUSTRALIA
- 16.4.5.1 Research-intensive institutions and biotech pipelines to sustain high-value peptide demand
- 16.4.6 REST OF ASIA PACIFIC
- 16.4.1 CHINA
- 16.5 LATIN AMERICA
- 16.5.1 BRAZIL
- 16.5.1.1 Large research base and metabolic-disease focus to make Brazil core Latin American market
- 16.5.2 MEXICO
- 16.5.2.1 US-linked manufacturing and clinical research to support peptide synthesis demand
- 16.5.3 REST OF LATIN AMERICA
- 16.5.1 BRAZIL
- 16.6 MIDDLE EAST
- 16.6.1 GCC COUNTRIES
- 16.6.1.1 Saudi Arabia
- 16.6.1.1.1 Localization initiatives and research funding to support rising peptide workflow adoption
- 16.6.1.2 UAE
- 16.6.1.2.1 Biotech hubs and regional distribution to strengthen access to peptide synthesis solutions
- 16.6.1.3 Rest of GCC Countries
- 16.6.1.1 Saudi Arabia
- 16.6.2 REST OF MIDDLE EAST
- 16.6.1 GCC COUNTRIES
- 16.7 AFRICA
- 16.7.1 RESEARCH-LED DEMAND AND IMPORT DEPENDENCE TO SHAPE MARKET
17 COMPETITIVE LANDSCAPE
- 17.1 OVERVIEW
- 17.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 17.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PEPTIDE SYNTHESIS MARKET
- 17.3 REVENUE ANALYSIS, 2021-2025
- 17.4 MARKET SHARE ANALYSIS, 2025
- 17.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2025
- 17.5.1 STARS
- 17.5.2 EMERGING LEADERS
- 17.5.3 PERVASIVE PLAYERS
- 17.5.4 PARTICIPANTS
- 17.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 17.5.5.1 Company footprint
- 17.5.5.2 Region footprint
- 17.5.5.3 Offering footprint
- 17.5.5.4 Product type footprint
- 17.5.5.5 Application footprint
- 17.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 17.6.1 PROGRESSIVE COMPANIES
- 17.6.2 RESPONSIVE COMPANIES
- 17.6.3 DYNAMIC COMPANIES
- 17.6.4 STARTING BLOCKS
- 17.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
- 17.6.5.1 Detailed list of key startups/SMEs
- 17.6.5.2 Competitive benchmarking of key startups/SMEs
- 17.7 COMPANY VALUATION & FINANCIAL METRICS
- 17.7.1 FINANCIAL METRICS
- 17.7.2 COMPANY VALUATION
- 17.8 PRODUCT/SERVICE COMPARISON
- 17.9 COMPETITIVE SCENARIO
- 17.9.1 PRODUCT LAUNCHES
- 17.9.2 DEALS
- 17.9.3 EXPANSIONS
18 COMPANY PROFILES
- 18.1 KEY PLAYERS
- 18.1.1 THERMO FISHER SCIENTIFIC INC.
- 18.1.1.1 Business overview
- 18.1.1.2 Products & services offered
- 18.1.1.3 Recent developments
- 18.1.1.3.1 Product launches
- 18.1.1.3.2 Deals
- 18.1.1.3.3 Expansions
- 18.1.1.4 MnM view
- 18.1.1.4.1 Right to win
- 18.1.1.4.2 Strategic choices
- 18.1.1.4.3 Weaknesses & competitive threats
- 18.1.2 MERCK KGAA
- 18.1.2.1 Business overview
- 18.1.2.2 Products & services offered
- 18.1.2.3 Recent developments
- 18.1.2.3.1 Deals
- 18.1.2.3.2 Expansions
- 18.1.2.4 MnM view
- 18.1.2.4.1 Right to win
- 18.1.2.4.2 Strategic choices
- 18.1.2.4.3 Weaknesses & competitive threats
- 18.1.3 AGILENT TECHNOLOGIES, INC.
- 18.1.3.1 Business overview
- 18.1.3.2 Products & services offered
- 18.1.3.3 Recent developments
- 18.1.3.3.1 Product launches
- 18.1.3.4 MnM view
- 18.1.3.4.1 Right to win
- 18.1.3.4.2 Strategic choices
- 18.1.3.4.3 Weaknesses and competitive threats
- 18.1.4 GENSCRIPT BIOTECH CORPORATION
- 18.1.4.1 Business overview
- 18.1.4.2 Products & services offered
- 18.1.4.3 Recent developments
- 18.1.4.3.1 Expansions
- 18.1.4.4 MnM view
- 18.1.4.4.1 Right to win
- 18.1.4.4.2 Strategic choices
- 18.1.4.4.3 Weaknesses & competitive threats
- 18.1.5 KANEKA CORPORATION
- 18.1.5.1 Business overview
- 18.1.5.2 Products & services offered
- 18.1.5.3 Recent developments
- 18.1.5.3.1 Expansions
- 18.1.5.4 MnM view
- 18.1.5.4.1 Right to win
- 18.1.5.4.2 Strategic choices
- 18.1.5.4.3 Weaknesses & competitive threats
- 18.1.6 SARTORIUS AG
- 18.1.6.1 Business overview
- 18.1.6.2 Products & services offered
- 18.1.6.3 Recent developments
- 18.1.6.3.1 Expansions
- 18.1.7 BACHEM HOLDING AG
- 18.1.7.1 Business overview
- 18.1.7.2 Products & services offered
- 18.1.7.3 Recent developments
- 18.1.7.3.1 Deals
- 18.1.7.3.2 Expansions
- 18.1.8 BIOTAGE AB
- 18.1.8.1 Business overview
- 18.1.8.2 Products & services offered
- 18.1.8.3 Recent developments
- 18.1.8.3.1 Product launches
- 18.1.8.3.2 Deals
- 18.1.9 CEM CORPORATION
- 18.1.9.1 Business overview
- 18.1.9.2 Products & services offered
- 18.1.9.3 Recent developments
- 18.1.9.3.1 Product launches
- 18.1.10 BIO-SYNTHESIS, INC.
- 18.1.10.1 Business overview
- 18.1.10.2 Products & services offered
- 18.1.11 BIOSYNTH
- 18.1.11.1 Business overview
- 18.1.11.2 Products & services offered
- 18.1.11.3 Recent developments
- 18.1.11.3.1 Deals
- 18.1.11.3.2 Expansions
- 18.1.12 CSBIO
- 18.1.12.1 Business overview
- 18.1.12.2 Products & services offered
- 18.1.13 GL BIOCHEM (SHANGHAI) LTD.
- 18.1.13.1 Business overview
- 18.1.13.2 Products & services offered
- 18.1.14 MESA LABORATORIES, INC.
- 18.1.14.1 Business overview
- 18.1.14.2 Products & services offered
- 18.1.14.3 Recent developments
- 18.1.14.3.1 Product & service launches
- 18.1.14.3.2 Deals
- 18.1.15 DANAHER CORPORATION
- 18.1.15.1 Business overview
- 18.1.15.2 Products & services offered
- 18.1.15.3 Recent developments
- 18.1.15.3.1 Product launches
- 18.1.1 THERMO FISHER SCIENTIFIC INC.
- 18.2 OTHER PLAYERS
- 18.2.1 CHEM-IMPEX INTERNATIONAL, INC.
- 18.2.2 ADVANCED CHEMTECH
- 18.2.3 MIMOTOPES PTY LTD.
- 18.2.4 IRIS BIOTECH GMBH
- 18.2.5 AAPPTEC, LLC
- 18.2.6 ENAMINE LTD.
- 18.2.7 INTAVIS PEPTIDE SERVICES GMBH
- 18.2.8 JPT PEPTIDE TECHNOLOGIES GMBH
- 18.2.9 INNOVAGEN AB
- 18.2.10 PEPTIDE PROTEIN RESEARCH LTD.
- 18.2.11 LIFETEIN LLC
- 18.2.12 CREATIVE PEPTIDES
- 18.2.13 GENEMED SYNTHESIS, INC.
- 18.2.14 CHINAPEPTIDES CO., LTD.
- 18.2.15 BEIJING SCILIGHT BIOTECHNOLOGY LTD. CO.
19 RESEARCH METHODOLOGY
- 19.1 RESEARCH DATA
- 19.1.1 SECONDARY DATA
- 19.1.1.1 Key secondary sources
- 19.1.1.2 Key data from secondary research
- 19.1.2 PRIMARY DATA
- 19.1.2.1 Key primary participants
- 19.1.2.2 Breakdown of primary interviews
- 19.1.2.3 Key data from primary sources
- 19.1.1 SECONDARY DATA
- 19.2 MARKET SIZE ESTIMATION
- 19.2.1 GLOBAL PEPTIDE SYNTHESIS MARKET ESTIMATION, 2025
- 19.2.1.1 Approach 1: Company revenue analysis-based estimation (bottom-up)
- 19.2.1.2 Approach 2: Primary research
- 19.2.1.2.1 Key industry insights
- 19.2.1.3 Approach 3: MnM repository analysis
- 19.2.2 SEGMENTAL MARKET SIZE ESTIMATION, 2025
- 19.2.1 GLOBAL PEPTIDE SYNTHESIS MARKET ESTIMATION, 2025
- 19.3 MARKET GROWTH RATE PROJECTIONS
- 19.4 DATA TRIANGULATION
- 19.5 RESEARCH ASSUMPTIONS
- 19.6 RESEARCH LIMITATIONS & RISK ASSESSMENT
20 APPENDIX
- 20.1 DISCUSSION GUIDE
- 20.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 20.3 CUSTOMIZATION OPTIONS
- 20.4 RELATED REPORTS
- 20.5 AUTHOR DETAILS
Product Code: BT 6462
List of Tables
- TABLE 1 PEPTIDE SYNTHESIS MARKET: INCLUSIONS & EXCLUSIONS
- TABLE 2 GLOBAL PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS
- TABLE 3 LIST OF SOME LATE-STAGE PEPTIDE THERAPEUTICS
- TABLE 4 PEPTIDE SYNTHESIS MARKET: IMPACT OF PORTER'S FIVE FORCES
- TABLE 5 PEPTIDE SYNTHESIS MARKET: ROLE IN ECOSYSTEM
- TABLE 6 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2023-2025 (USD)
- TABLE 7 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2023-2025 (USD)
- TABLE 8 IMPORT DATA FOR HS CODE 902720, 2021-2025 (USD THOUSAND)
- TABLE 9 IMPORT DATA FOR HS CODE 902720, 2021-2025 (UNITS)
- TABLE 10 EXPORT DATA FOR HS CODE 902720, 2021-2025 (USD THOUSAND)
- TABLE 11 EXPORT DATA FOR HS CODE 902720, 2021-2025 (TONS)
- TABLE 12 IMPORT DATA FOR HS CODE 841933, 2022-2025 (USD THOUSAND)
- TABLE 13 IMPORT DATA FOR HS CODE 841933, 2022-2025 (UNITS)
- TABLE 14 EXPORT DATA FOR HS CODE 841933, 2022-2025 (USD THOUSAND)
- TABLE 15 EXPORT DATA FOR HS CODE 841933, 2022-2025 (TONS)
- TABLE 16 PEPTIDE SYNTHESIS MARKET: KEY CONFERENCES & EVENTS, 2026-2027
- TABLE 17 PEPTIDE SYNTHESIS MARKET: INDICATIVE LIST OF PATENTS, 2026
- TABLE 18 CASE STUDIES OF AI IMPLEMENTATION IN PEPTIDE SYNTHESIS MARKET
- TABLE 19 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN PEPTIDE SYNTHESIS
- TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING TYPE (%)
- TABLE 25 KEY BUYING CRITERIA, BY END USER
- TABLE 26 PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 27 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 28 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 29 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 30 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 31 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 32 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 33 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 34 PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 35 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 36 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 37 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 38 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 39 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 40 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 41 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 42 PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 43 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 44 EUROPE: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 45 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 46 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 47 MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 48 GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 49 PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 50 PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 51 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 52 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 53 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 54 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 55 MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 56 GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 57 PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 58 AMINO ACID BUILDING BLOCKS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 59 NORTH AMERICA: AMINO ACID BUILDING BLOCKS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 60 EUROPE: AMINO ACID BUILDING BLOCKS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 61 ASIA PACIFIC: AMINO ACID BUILDING BLOCKS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 62 LATIN AMERICA: AMINO ACID BUILDING BLOCKS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 63 MIDDLE EAST: AMINO ACID BUILDING BLOCKS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 64 GCC COUNTRIES: AMINO ACID BUILDING BLOCKS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 65 RESINS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 66 NORTH AMERICA: RESINS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 67 EUROPE: RESINS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 68 ASIA PACIFIC: RESINS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 69 LATIN AMERICA: RESINS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 70 MIDDLE EAST: RESINS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 71 GCC COUNTRIES: RESINS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 72 COUPLING REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 73 NORTH AMERICA: COUPLING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 74 EUROPE: COUPLING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 75 ASIA PACIFIC: COUPLING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 76 LATIN AMERICA: COUPLING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 77 MIDDLE EAST: COUPLING REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 78 GCC COUNTRIES: COUPLING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 79 PEPTIDE MODIFICATION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 80 NORTH AMERICA: PEPTIDE MODIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 81 EUROPE: PEPTIDE MODIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 82 ASIA PACIFIC: PEPTIDE MODIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 83 LATIN AMERICA: PEPTIDE MODIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 84 MIDDLE EAST: PEPTIDE MODIFICATION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 85 GCC COUNTRIES: PEPTIDE MODIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 86 LABELING REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 87 NORTH AMERICA: LABELING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 88 EUROPE: LABELING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 89 ASIA PACIFIC: LABELING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 90 LATIN AMERICA: LABELING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 91 MIDDLE EAST: LABELING REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 92 GCC COUNTRIES: LABELING REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 93 PROTECTION & DEPROTECTION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 94 NORTH AMERICA: PROTECTION & DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 95 EUROPE: PROTECTION & DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 96 ASIA PACIFIC: PROTECTION & DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 97 LATIN AMERICA: PROTECTION & DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 98 MIDDLE EAST: PROTECTION & DEPROTECTION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 99 GCC COUNTRIES: PROTECTION & DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 100 CLEAVAGE REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 101 NORTH AMERICA: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 102 EUROPE: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 103 ASIA PACIFIC: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 104 LATIN AMERICA: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 105 MIDDLE EAST: CLEAVAGE REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 106 GCC COUNTRIES: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 107 OTHER REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 108 NORTH AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 109 EUROPE: OTHER REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 110 ASIA PACIFIC: OTHER REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 111 LATIN AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 112 MIDDLE EAST: OTHER REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 113 GCC COUNTRIES: OTHER REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 114 PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 115 NORTH AMERICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 116 EUROPE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 117 ASIA PACIFIC: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 118 LATIN AMERICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 119 MIDDLE EAST: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 120 GCC COUNTRIES: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 121 PEPTIDE SYNTHESIS INSTRUMENTS: SELECTED PRODUCTS OFFERED BY KEY SUPPLIERS
- TABLE 122 PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 123 NORTH AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 124 EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 125 ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 126 LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 127 MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 128 GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 129 PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 130 PEPTIDE SYNTHESIZERS: SELECTED PRODUCTS OFFERED BY KEY SUPPLIERS
- TABLE 131 PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 132 NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 133 EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 134 ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 135 LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 136 MIDDLE EAST: PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 137 GCC COUNTRIES: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 138 PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 139 PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 140 AUTOMATED PEPTIDE SYNTHESIZERS: SELECTED PRODUCT EXAMPLES
- TABLE 141 AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 142 NORTH AMERICA: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 143 EUROPE: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 144 ASIA PACIFIC: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 145 LATIN AMERICA: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 146 MIDDLE EAST: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 147 GCC COUNTRIES: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 148 MANUAL PEPTIDE SYNTHESIZERS: SELECTED PRODUCT EXAMPLES
- TABLE 149 MANUAL PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 150 NORTH AMERICA: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 151 EUROPE: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 152 ASIA PACIFIC: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 153 LATIN AMERICA: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 154 MIDDLE EAST: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 155 GCC COUNTRIES: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 156 CONVENTIONAL-BATCH PEPTIDE SYNTHESIZERS: SELECTED PRODUCT EXAMPLES
- TABLE 157 CONVENTIONAL-BATCH PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 158 NORTH AMERICA: CONVENTIONAL-BATCH PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 159 EUROPE: CONVENTIONAL-BATCH PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 160 ASIA PACIFIC: CONVENTIONAL-BATCH PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 161 LATIN AMERICA: CONVENTIONAL-BATCH PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 162 MIDDLE EAST: CONVENTIONAL-BATCH PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 163 GCC COUNTRIES: CONVENTIONAL-BATCH PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 164 MICROWAVE-ASSISTED PEPTIDE SYNTHESIZERS: SELECTED PRODUCT EXAMPLES
- TABLE 165 MICROWAVE-ASSISTED PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 166 NORTH AMERICA: MICROWAVE-ASSISTED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 167 EUROPE: MICROWAVE-ASSISTED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 168 ASIA PACIFIC: MICROWAVE-ASSISTED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 169 LATIN AMERICA: MICROWAVE-ASSISTED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 170 MIDDLE EAST: MICROWAVE-ASSISTED PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 171 GCC COUNTRIES: MICROWAVE-ASSISTED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 172 HYBRID PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 173 NORTH AMERICA: HYBRID PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 174 EUROPE: HYBRID PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 175 ASIA PACIFIC: HYBRID PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 176 LATIN AMERICA: HYBRID PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 177 MIDDLE EAST: HYBRID PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 178 GCC COUNTRIES: HYBRID PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 179 OTHER PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 180 NORTH AMERICA: OTHER PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 181 EUROPE: OTHER PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 182 ASIA PACIFIC: OTHER PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 183 LATIN AMERICA: OTHER PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 184 MIDDLE EAST: OTHER PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 185 GCC COUNTRIES: OTHER PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 186 PURIFICATION SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 187 NORTH AMERICA: PURIFICATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 188 EUROPE: PURIFICATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 189 ASIA PACIFIC: PURIFICATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 190 LATIN AMERICA: PURIFICATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 191 MIDDLE EAST: PURIFICATION SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 192 GCC COUNTRIES: PURIFICATION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 193 ANALYTICAL & QUALITY CONTROL INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 194 NORTH AMERICA: ANALYTICAL & QUALITY CONTROL INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 195 EUROPE: ANALYTICAL & QUALITY CONTROL INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 196 ASIA PACIFIC: ANALYTICAL & QUALITY CONTROL INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 197 LATIN AMERICA: ANALYTICAL & QUALITY CONTROL INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 198 MIDDLE EAST: ANALYTICAL & QUALITY CONTROL INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 199 GCC COUNTRIES: ANALYTICAL & QUALITY CONTROL INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 200 LYOPHILIZATION EQUIPMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 201 NORTH AMERICA: LYOPHILIZATION EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 202 EUROPE: LYOPHILIZATION EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 203 ASIA PACIFIC: LYOPHILIZATION EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 204 LATIN AMERICA: LYOPHILIZATION EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 205 MIDDLE EAST: LYOPHILIZATION EQUIPMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 206 GCC COUNTRIES: LYOPHILIZATION EQUIPMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 207 OTHER INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 208 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 209 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 210 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 211 LATIN AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 212 MIDDLE EAST: OTHER INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 213 GCC COUNTRIES: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 214 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 215 CHEMICAL PEPTIDE SYNTHESIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 216 NORTH AMERICA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 217 EUROPE: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 218 ASIA PACIFIC: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 219 LATIN AMERICA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 220 MIDDLE EAST: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 221 GCC COUNTRIES: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 222 CHEMICAL PEPTIDE SYNTHESIS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 223 SOLID-PHASE PEPTIDE SYNTHESIS (SPPS) MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 224 NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS (SPPS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 225 EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS (SPPS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 226 ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS (SPPS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 227 LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS (SPPS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 228 MIDDLE EAST: SOLID-PHASE PEPTIDE SYNTHESIS (SPPS) MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 229 GCC COUNTRIES: SOLID-PHASE PEPTIDE SYNTHESIS (SPPS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 230 LIQUID-PHASE PEPTIDE SYNTHESIS (LPPS) MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 231 NORTH AMERICA: LIQUID-PHASE PEPTIDE SYNTHESIS (LPPS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 232 EUROPE: LIQUID-PHASE PEPTIDE SYNTHESIS (LPPS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 233 ASIA PACIFIC: LIQUID-PHASE PEPTIDE SYNTHESIS (LPPS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 234 LATIN AMERICA: LIQUID-PHASE PEPTIDE SYNTHESIS (LPPS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 235 MIDDLE EAST: LIQUID-PHASE PEPTIDE SYNTHESIS (LPPS) MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 236 GCC COUNTRIES: LIQUID-PHASE PEPTIDE SYNTHESIS (LPPS) MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 237 CHEMICAL PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 238 NORTH AMERICA: CHEMICAL PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 239 EUROPE: CHEMICAL PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 240 ASIA PACIFIC: CHEMICAL PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 241 LATIN AMERICA: CHEMICAL PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 242 MIDDLE EAST: CHEMICAL PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 243 GCC COUNTRIES: CHEMICAL PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 244 BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 245 NORTH AMERICA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 246 EUROPE: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 247 ASIA PACIFIC: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 248 LATIN AMERICA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 249 MIDDLE EAST: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 250 GCC COUNTRIES: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 251 BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 252 RECOMBINANT PEPTIDE PRODUCTION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 253 NORTH AMERICA: RECOMBINANT PEPTIDE PRODUCTION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 254 EUROPE: RECOMBINANT PEPTIDE PRODUCTION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 255 ASIA PACIFIC: RECOMBINANT PEPTIDE PRODUCTION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 256 LATIN AMERICA: RECOMBINANT PEPTIDE PRODUCTION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 257 MIDDLE EAST: RECOMBINANT PEPTIDE PRODUCTION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 258 GCC COUNTRIES: RECOMBINANT PEPTIDE PRODUCTION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 259 ENZYMATIC PEPTIDE SYNTHESIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 260 NORTH AMERICA: ENZYMATIC PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 261 EUROPE: ENZYMATIC PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 262 ASIA PACIFIC: ENZYMATIC PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 263 LATIN AMERICA: ENZYMATIC PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 264 MIDDLE EAST: ENZYMATIC PEPTIDE SYNTHESIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 265 GCC COUNTRIES: ENZYMATIC PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 266 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 267 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 268 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 269 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 270 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 271 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 272 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 273 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 274 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 275 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 276 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 277 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 278 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 279 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 280 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 281 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 282 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 283 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 284 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 285 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 286 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 287 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 288 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 289 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 290 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 291 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 292 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 293 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 294 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 295 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 296 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 297 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 298 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 299 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 300 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 301 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 302 PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 303 CUSTOM PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 304 NORTH AMERICA: CUSTOM PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 305 EUROPE: CUSTOM PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 306 ASIA PACIFIC: CUSTOM PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 307 LATIN AMERICA: CUSTOM PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 308 MIDDLE EAST: CUSTOM PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 309 GCC COUNTRIES: CUSTOM PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 310 PEPTIDE ENGINEERING & MODIFICATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 311 NORTH AMERICA: PEPTIDE ENGINEERING & MODIFICATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 312 EUROPE: PEPTIDE ENGINEERING & MODIFICATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 313 ASIA PACIFIC: PEPTIDE ENGINEERING & MODIFICATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 314 LATIN AMERICA: PEPTIDE ENGINEERING & MODIFICATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 315 MIDDLE EAST: PEPTIDE ENGINEERING & MODIFICATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 316 GCC COUNTRIES: PEPTIDE ENGINEERING & MODIFICATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 317 PEPTIDE PURIFICATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 318 NORTH AMERICA: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 319 EUROPE: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 320 ASIA PACIFIC: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 321 LATIN AMERICA: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 322 MIDDLE EAST: PEPTIDE PURIFICATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 323 GCC COUNTRIES: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 324 PEPTIDE ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 325 NORTH AMERICA: PEPTIDE ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 326 EUROPE: PEPTIDE ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 327 ASIA PACIFIC: PEPTIDE ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 328 LATIN AMERICA: PEPTIDE ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 329 MIDDLE EAST: PEPTIDE ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 330 GCC COUNTRIES: PEPTIDE ANALYTICAL & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 331 PEPTIDE LIBRARY PREPARATION/SYNTHESIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 332 NORTH AMERICA: PEPTIDE LIBRARY PREPARATION/SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 333 EUROPE: PEPTIDE LIBRARY PREPARATION/SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 334 ASIA PACIFIC: PEPTIDE LIBRARY PREPARATION/SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 335 LATIN AMERICA: PEPTIDE LIBRARY PREPARATION/SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 336 MIDDLE EAST: PEPTIDE LIBRARY PREPARATION/SYNTHESIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 337 GCC COUNTRIES: PEPTIDE LIBRARY PREPARATION/SYNTHESIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 338 PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 339 PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 340 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 341 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 342 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 343 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 344 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 345 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 346 PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 347 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 348 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 349 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 350 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 351 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 352 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 353 PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 354 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 355 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 356 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 357 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 358 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 359 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 360 PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 361 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 362 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 363 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 364 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 365 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 366 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 367 PEPTIDE SYNTHESIS SERVICES MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 368 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 369 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 370 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 371 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 372 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 373 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 374 PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 375 PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 376 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 377 EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 378 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 379 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 380 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 381 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 382 PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 383 PEPTIDE SYNTHESIS MARKET FOR DIABETES APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 384 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIABETES APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 385 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DIABETES APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 386 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DIABETES APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 387 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIABETES APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 388 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DIABETES APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 389 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DIABETES APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 390 PEPTIDE SYNTHESIS MARKET FOR OBESITY APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 391 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OBESITY APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 392 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OBESITY APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 393 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OBESITY APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 394 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OBESITY APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 395 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OBESITY APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 396 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OBESITY APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 397 PEPTIDE SYNTHESIS MARKET FOR CANCER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 398 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CANCER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 399 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CANCER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 400 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CANCER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 401 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CANCER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 402 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CANCER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 403 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CANCER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 404 PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASE APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 405 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 406 EUROPE: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 407 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 408 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 409 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASE APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 410 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 411 PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC INDICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 412 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC INDICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 413 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC INDICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 414 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC INDICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 415 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC INDICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 416 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC INDICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 417 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC INDICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 418 PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 419 PEPTIDE SYNTHESIS MARKET FOR METABOLIC & HORMONAL PEPTIDES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 420 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR METABOLIC & HORMONAL PEPTIDES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 421 EUROPE: PEPTIDE SYNTHESIS MARKET FOR METABOLIC & HORMONAL PEPTIDES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 422 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR METABOLIC & HORMONAL PEPTIDES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 423 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR METABOLIC & HORMONAL PEPTIDES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 424 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR METABOLIC & HORMONAL PEPTIDES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 425 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR METABOLIC & HORMONAL PEPTIDES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 426 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 427 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 428 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 429 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 430 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 431 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 432 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 433 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES (PDCS), BY REGION, 2024-2031 (USD MILLION)
- TABLE 434 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES (PDCS), BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 435 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES (PDCS), BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 436 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES (PDCS), BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 437 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES (PDCS), BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 438 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES (PDCS), BY REGION, 2024-2031 (USD MILLION)
- TABLE 439 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES (PDCS), BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 440 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 441 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 442 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 443 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 444 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 445 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 446 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 447 PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC MODALITIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 448 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC MODALITIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 449 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC MODALITIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 450 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC MODALITIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 451 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC MODALITIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 452 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC MODALITIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 453 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER THERAPEUTIC MODALITIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 454 PEPTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 455 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 456 EUROPE: PEPTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 457 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 458 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 459 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 460 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 461 PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 462 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 463 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 464 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 465 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 466 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 467 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 468 PEPTIDE SYNTHESIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 469 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 470 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 471 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 472 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 473 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 474 NORTH AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 475 NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 476 NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 477 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 478 NORTH AMERICA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 479 NORTH AMERICA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 480 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 481 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 482 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 483 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 484 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 485 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 486 US: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 487 US: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 488 US: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 489 US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 490 US: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 491 US: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 492 US: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 493 US: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 494 US: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 495 US: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 496 US: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 497 US: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 498 US: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 499 US: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 500 US: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 501 US: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 502 CANADA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 503 CANADA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 504 CANADA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 505 CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 506 CANADA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 507 CANADA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 508 CANADA: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 509 CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 510 CANADA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 511 CANADA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 512 CANADA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 513 CANADA: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 514 CANADA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 515 CANADA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 516 CANADA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 517 CANADA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 518 EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 519 EUROPE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 520 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 521 EUROPE: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 522 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 523 EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 524 EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 525 EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 526 EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 527 EUROPE: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 528 EUROPE: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 529 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 530 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 531 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 532 EUROPE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 533 EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 534 EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 535 GERMANY: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 536 GERMANY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 537 GERMANY: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 538 GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 539 GERMANY: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 540 GERMANY: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 541 GERMANY: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 542 GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 543 GERMANY: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 544 GERMANY: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 545 GERMANY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 546 GERMANY: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 547 GERMANY: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 548 GERMANY: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 549 GERMANY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 550 GERMANY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 551 UK: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 552 UK: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 553 UK: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 554 UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 555 UK: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 556 UK: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 557 UK: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 558 UK: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 559 UK: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 560 UK: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 561 UK: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 562 UK: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 563 UK: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 564 UK: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 565 UK: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 566 UK: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 567 FRANCE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 568 FRANCE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 569 FRANCE: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 570 FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 571 FRANCE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 572 FRANCE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 573 FRANCE: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 574 FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 575 FRANCE: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 576 FRANCE: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 577 FRANCE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 578 FRANCE: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 579 FRANCE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 580 FRANCE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 581 FRANCE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 582 FRANCE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 583 ITALY: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 584 ITALY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 585 ITALY: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 586 ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 587 ITALY: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 588 ITALY: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 589 ITALY: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 590 ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 591 ITALY: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 592 ITALY: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 593 ITALY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 594 ITALY: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 595 ITALY: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 596 ITALY: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 597 ITALY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 598 ITALY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 599 SPAIN: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 600 SPAIN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 601 SPAIN: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 602 SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 603 SPAIN: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 604 SPAIN: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 605 SPAIN: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 606 SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 607 SPAIN: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 608 SPAIN: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 609 SPAIN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 610 SPAIN: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 611 SPAIN: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 612 SPAIN: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 USD MILLION)
- TABLE 613 SPAIN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 614 SPAIN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 615 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 616 REST OF EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 617 REST OF EUROPE: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 618 REST OF EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 619 REST OF EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 620 REST OF EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 621 REST OF EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 622 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 623 REST OF EUROPE: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 624 REST OF EUROPE: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 625 REST OF EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 626 REST OF EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 627 REST OF EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 628 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 629 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 630 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 631 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 632 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 633 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 634 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 635 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 636 ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 637 ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 638 ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 639 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 640 ASIA PACIFIC: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 641 ASIA PACIFIC: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 642 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 643 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 644 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 645 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 646 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 647 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 648 CHINA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 649 CHINA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 650 CHINA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 651 CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 652 CHINA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 653 CHINA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 654 CHINA: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 655 CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 656 CHINA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 657 CHINA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 658 CHINA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 659 CHINA: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 660 CHINA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 661 CHINA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 662 CHINA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 663 CHINA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 664 JAPAN: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 665 JAPAN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 666 JAPAN: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 667 JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 668 JAPAN: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 669 JAPAN: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 670 JAPAN: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 671 JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 672 JAPAN: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 673 JAPAN: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 674 JAPAN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 675 JAPAN: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 676 JAPAN: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 677 JAPAN: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 678 JAPAN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 679 JAPAN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 680 INDIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 681 INDIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 682 INDIA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 683 INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 684 INDIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 685 INDIA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 686 INDIA: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 687 INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 688 INDIA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 689 INDIA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 690 INDIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 691 INDIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 692 INDIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 693 INDIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 694 INDIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 695 INDIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 696 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 697 SOUTH KOREA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 698 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 699 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 700 SOUTH KOREA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 701 SOUTH KOREA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 702 SOUTH KOREA: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 703 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 704 SOUTH KOREA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 705 SOUTH KOREA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 706 SOUTH KOREA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 707 SOUTH KOREA: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 708 SOUTH KOREA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 709 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 710 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 711 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 712 AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 713 AUSTRALIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 714 AUSTRALIA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 715 AUSTRALIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 716 AUSTRALIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 717 AUSTRALIA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 718 AUSTRALIA: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 719 AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 720 AUSTRALIA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 721 AUSTRALIA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 722 AUSTRALIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 723 AUSTRALIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 724 AUSTRALIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 725 AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 726 AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 727 AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 728 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 729 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 730 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 731 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 732 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 733 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 734 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 735 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 736 REST OF ASIA PACIFIC: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 737 REST OF ASIA PACIFIC: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 738 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 739 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 740 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 741 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 742 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 743 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 744 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 745 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 746 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 747 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 748 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 749 LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 750 LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 751 LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 752 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 753 LATIN AMERICA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 754 LATIN AMERICA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 755 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 756 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 757 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 758 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 759 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 760 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 761 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 762 BRAZIL: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 763 BRAZIL: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 764 BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 765 BRAZIL: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 766 BRAZIL: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 767 BRAZIL: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 768 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 769 BRAZIL: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 770 BRAZIL: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 771 BRAZIL: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 772 BRAZIL: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 773 BRAZIL: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 774 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 775 BRAZIL: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 776 BRAZIL: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 777 MEXICO: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 778 MEXICO: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 779 MEXICO: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 780 MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 781 MEXICO: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 782 MEXICO: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 783 MEXICO: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 784 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 785 MEXICO: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 786 MEXICO: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 787 MEXICO: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 788 MEXICO: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 789 MEXICO: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 790 MEXICO: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 791 MEXICO: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 792 MEXICO: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 793 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 794 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 795 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 796 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 797 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 798 REST OF LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 799 REST OF LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 800 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 801 REST OF LATIN AMERICA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 802 REST OF LATIN AMERICA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 803 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 804 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 805 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 806 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 807 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 808 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 809 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 810 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 811 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 812 MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 813 MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 814 MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 815 MIDDLE EAST: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 816 MIDDLE EAST: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 817 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 818 MIDDLE EAST: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 819 MIDDLE EAST: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 820 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 821 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 822 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 823 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 824 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 825 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 826 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 827 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 828 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 829 GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 830 GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 831 GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 832 GCC COUNTRIES: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 833 GCC COUNTRIES: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 834 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 835 GCC COUNTRIES: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 836 GCC COUNTRIES: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 837 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 838 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 839 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 840 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 841 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 842 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 843 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 844 SAUDI ARABIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 845 SAUDI ARABIA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 846 SAUDI ARABIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 847 SAUDI ARABIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 848 SAUDI ARABIA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 849 SAUDI ARABIA: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 850 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 851 SAUDI ARABIA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 852 SAUDI ARABIA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 853 SAUDI ARABIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 854 SAUDI ARABIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 855 SAUDI ARABIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 856 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 857 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 858 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 859 UAE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 860 UAE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 861 UAE: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 862 UAE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 863 UAE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 864 UAE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 865 UAE: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 866 UAE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 867 UAE: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 868 UAE: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 869 UAE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 870 UAE: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 871 UAE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 872 UAE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 873 UAE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 874 UAE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 875 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 876 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 877 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 878 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 879 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 880 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 881 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 882 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 883 REST OF GCC COUNTRIES: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 884 REST OF GCC COUNTRIES: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 885 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 886 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 887 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 888 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 889 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 890 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 891 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 892 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 893 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 894 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 895 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 896 REST OF MIDDLE EAST: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 897 REST OF MIDDLE EAST: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 898 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 899 REST OF MIDDLE EAST: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 900 REST OF MIDDLE EAST: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 901 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 902 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 903 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 904 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 905 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 906 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 907 AFRICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 908 AFRICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
- TABLE 909 AFRICA: PEPTIDE SYNTHESIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 910 AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 911 AFRICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 912 AFRICA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 913 AFRICA: PEPTIDE SYNTHESIZERS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 914 AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024-2031 (USD MILLION)
- TABLE 915 AFRICA: CHEMICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 916 AFRICA: BIOLOGICAL PEPTIDE SYNTHESIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 917 AFRICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 918 AFRICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY SERVICE TYPE, 2024-2031 (USD MILLION)
- TABLE 919 AFRICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 920 AFRICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 921 AFRICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY DISEASE INDICATION, 2024-2031 (USD MILLION)
- TABLE 922 AFRICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2024-2031 (USD MILLION)
- TABLE 923 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PEPTIDE SYNTHESIS MARKET
- TABLE 924 PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION
- TABLE 925 PEPTIDE SYNTHESIS MARKET: REGION FOOTPRINT
- TABLE 926 PEPTIDE SYNTHESIS MARKET: OFFERING FOOTPRINT
- TABLE 927 PEPTIDE SYNTHESIS MARKET: PRODUCT TYPE FOOTPRINT
- TABLE 928 PEPTIDE SYNTHESIS MARKET: APPLICATION FOOTPRINT
- TABLE 929 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
- TABLE 930 PEPTIDE SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY OFFERING AND REGION
- TABLE 931 PEPTIDE SYNTHESIS MARKET: PRODUCT LAUNCHES, JANUARY 2023- AUGUST 2026
- TABLE 932 PEPTIDE SYNTHESIS MARKET: DEALS, JANUARY 2023-AUGUST 2026
- TABLE 933 PEPTIDE SYNTHESIS MARKET: EXPANSIONS, JANUARY 2023-AUGUST 2026
- TABLE 934 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 935 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
- TABLE 936 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023- AUGUST 2026
- TABLE 937 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023-AUGUST 2026
- TABLE 938 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023-AUGUST 2026
- TABLE 939 MERCK KGAA: COMPANY OVERVIEW
- TABLE 940 MERCK KGAA: PRODUCTS & SERVICES OFFERED
- TABLE 941 MERCK KGAA: DEALS, JANUARY 2023-AUGUST 2026
- TABLE 942 MERCK KGAA: EXPANSIONS, JANUARY 2023-AUGUST 2026
- TABLE 943 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 944 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 945 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023- AUGUST 2026
- TABLE 946 GENSCRIPT BIOTECH CORPORATION: COMPANY OVERVIEW
- TABLE 947 GENSCRIPT BIOTECH CORPORATION: PRODUCTS & SERVICES OFFERED
- TABLE 948 GENSCRIPT BIOTECH CORPORATION: EXPANSIONS, JANUARY 2023-AUGUST 2026
- TABLE 949 KANEKA CORPORATION: COMPANY OVERVIEW
- TABLE 950 KANEKA CORPORATION: PRODUCTS & SERVICES OFFERED
- TABLE 951 KANEKA CORPORATION: EXPANSIONS, JANUARY 2023-AUGUST 2026
- TABLE 952 SARTORIUS AG: COMPANY OVERVIEW
- TABLE 953 SARTORIUS AG: PRODUCTS & SERVICES OFFERED
- TABLE 954 SARTORIUS AG: EXPANSIONS, JANUARY 2023-AUGUST 2026
- TABLE 955 BACHEM HOLDING AG: COMPANY OVERVIEW
- TABLE 956 BACHEM HOLDING AG: PRODUCTS & SERVICES OFFERED
- TABLE 957 BACHEM HOLDING AG: DEALS, JANUARY 2023-AUGUST 2026
- TABLE 958 BACHEM HOLDING AG: EXPANSIONS, JANUARY 2023-AUGUST 2026
- TABLE 959 BIOTAGE AB: COMPANY OVERVIEW
- TABLE 960 BIOTAGE AB: PRODUCTS & SERVICES OFFERED
- TABLE 961 BIOTAGE AB: PRODUCT LAUNCHES, JANUARY 2023-AUGUST 2026
- TABLE 962 BIOTAGE AB: DEALS, JANUARY 2023-AUGUST 2026
- TABLE 963 CEM CORPORATION: COMPANY OVERVIEW
- TABLE 964 CEM CORPORATION: PRODUCTS & SERVICES OFFERED
- TABLE 965 CEM CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-AUGUST 2026
- TABLE 966 BIO-SYNTHESIS, INC.: COMPANY OVERVIEW
- TABLE 967 BIO-SYNTHESIS, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 968 BIOSYNTH: COMPANY OVERVIEW
- TABLE 969 BIOSYNTH: PRODUCTS & SERVICES OFFERED
- TABLE 970 BIOSYNTH: DEALS, JANUARY 2023-AUGUST 2026
- TABLE 971 BIOSYNTH: EXPANSIONS, JANUARY 2023-AUGUST 2026
- TABLE 972 CSBIO: COMPANY OVERVIEW
- TABLE 973 CSBIO: PRODUCTS & SERVICES OFFERED
- TABLE 974 GL BIOCHEM (SHANGHAI) LTD.: COMPANY OVERVIEW
- TABLE 975 GL BIOCHEM (SHANGHAI) LTD.: PRODUCTS & SERVICES OFFERED
- TABLE 976 MESA LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 977 MESA LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
- TABLE 978 MESA LABORATORIES, INC.: PRODUCT & SERVICE LAUNCHES, JANUARY 2023-AUGUST 2026
- TABLE 979 MESA LABORATORIES, INC.: DEALS, JANUARY 2023-AUGUST 2026
- TABLE 980 DANAHER CORPORATION: COMPANY OVERVIEW
- TABLE 981 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
- TABLE 982 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-AUGUST 2026
- TABLE 983 CHEM-IMPEX INTERNATIONAL, INC.: COMPANY OVERVIEW
- TABLE 984 ADVANCED CHEMTECH: COMPANY OVERVIEW
- TABLE 985 MIMOTOPES PTY LTD.: COMPANY OVERVIEW
- TABLE 986 IRIS BIOTECH GMBH: COMPANY OVERVIEW
- TABLE 987 AAPPTEC, LLC: COMPANY OVERVIEW
- TABLE 988 ENAMINE LTD.: COMPANY OVERVIEW
- TABLE 989 INTAVIS PEPTIDE SERVICES GMBH: COMPANY OVERVIEW
- TABLE 990 JPT PEPTIDE TECHNOLOGIES GMBH: COMPANY OVERVIEW
- TABLE 991 INNOVAGEN AB: COMPANY OVERVIEW
- TABLE 992 PEPTIDE PROTEIN RESEARCH LTD.: COMPANY OVERVIEW
- TABLE 993 LIFETEIN LLC: COMPANY OVERVIEW
- TABLE 994 CREATIVE PEPTIDES: COMPANY OVERVIEW
- TABLE 995 GENEMED SYNTHESIS, INC.: COMPANY OVERVIEW
- TABLE 996 CHINAPEPTIDES CO., LTD. (QYAOBIO): COMPANY OVERVIEW
- TABLE 997 BEIJING SCILIGHT BIOTECHNOLOGY LTD. CO.: COMPANY OVERVIEW
- TABLE 998 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
- TABLE 999 RISK ASSESSMENT
List of Figures
- FIGURE 1 PEPTIDE SYNTHESIS MARKET SEGMENTATION & REGIONAL SCOPE
- FIGURE 2 PEPTIDE SYNTHESIS MARKET: YEARS CONSIDERED
- FIGURE 3 MARKET SCENARIO
- FIGURE 4 GLOBAL PEPTIDE SYNTHESIS MARKET, 2024-2031
- FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PEPTIDE SYNTHESIS MARKET, 2023-2026
- FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PEPTIDE SYNTHESIS MARKET
- FIGURE 7 HIGH-GROWTH SEGMENTS IN PEPTIDE SYNTHESIS MARKET, 2026-2031
- FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PEPTIDE SYNTHESIS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
- FIGURE 9 SURGING DEMAND FOR GLP-1 AND OTHER PEPTIDE THERAPEUTICS TO DRIVE MARKET GROWTH
- FIGURE 10 PRODUCTS ACCOUNTED FOR LARGEST SHARE OF PEPTIDE SYNTHESIS MARKET IN NORTH AMERICA IN 2025
- FIGURE 11 CHINA IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL PEPTIDE SYNTHESIS MARKET DURING FORECAST PERIOD
- FIGURE 12 THERAPEUTIC APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD
- FIGURE 13 PEPTIDE SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 14 PEPTIDE SYNTHESIS MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 15 PEPTIDE SYNTHESIS MARKET: VALUE CHAIN ANALYSIS
- FIGURE 16 PEPTIDE SYNTHESIS MARKET ECOSYSTEM
- FIGURE 17 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TYPE, 2023-2025 (USD)
- FIGURE 18 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2025 (USD)
- FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- FIGURE 20 TOP APPLICANTS/OWNERS (COMPANIES) FOR PEPTIDE SYNTHESIS PATENTS, 2015-2025
- FIGURE 21 IMPACT OF AI/GEN AI ON PEPTIDE SYNTHESIS MARKET
- FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
- FIGURE 23 KEY BUYING CRITERIA, BY END USER
- FIGURE 24 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT
- FIGURE 25 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT
- FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN PEPTIDE SYNTHESIS MARKET, 2021-2025 (USD MILLION)
- FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PEPTIDE SYNTHESIS MARKET, 2025
- FIGURE 28 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 29 PEPTIDE SYNTHESIS MARKET: COMPANY FOOTPRINT
- FIGURE 30 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 31 EV/EBITDA OF KEY VENDORS
- FIGURE 32 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 33 PEPTIDE SYNTHESIS MARKET: PRODUCT/SERVICE COMPARATIVE ANALYSIS
- FIGURE 34 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
- FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2025)
- FIGURE 36 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 37 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 38 KANEKA CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2025)
- FIGURE 40 BACHEM HOLDING AG: COMPANY SNAPSHOT (2025)
- FIGURE 41 MESA LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 43 PEPTIDE SYNTHESIS MARKET: RESEARCH DESIGN
- FIGURE 44 PEPTIDE SYNTHESIS MARKET: BREAKDOWN OF PRIMARIES
- FIGURE 45 GLOBAL PEPTIDE SYNTHESIS MARKET ESTIMATION, 2025
- FIGURE 46 PEPTIDE SYNTHESIS MARKET: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) (2025)
- FIGURE 47 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC: REVENUE ANALYSIS (2025)
- FIGURE 48 PEPTIDE SYNTHESIS MARKET: INSIGHTS FROM PRIMARIES
- FIGURE 49 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
- FIGURE 50 PEPTIDE SYNTHESIS MARKET: CAGR PROJECTIONS
- FIGURE 51 PEPTIDE SYNTHESIS MARKET: DATA TRIANGULATION
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.